Showing posts with label IBS. Show all posts

Drug for Colitis, Crohn's Disease Shows Promise


By Amy Norton
HealthDay Reporter

WEDNESDAY, Aug. 21 (HealthDay News) -- An experimental drug may help some people who have inflammatory bowel disease that has failed to respond to current medications, two new clinical trials find.
The drug, called vedolizumab, is being developed to treat the two main forms of inflammatory bowel disease (IBD) -- ulcerative colitis and Crohn's disease. Both arise when the immune system launches an abnormal attack on the lining of the digestive tract, leading to chronic inflammation and symptoms such as abdominal cramps, diarrhea and rectal bleeding.
In the new trials, reported in the Aug. 22 issue of the New England Journal of Medicine, researchers found that vedolizumab worked in some cases where standard IBD medications had failed.
The drug was more effective for colitis than for Crohn's, however, and an expert not involved in the studies said he suspects vedolizumab might be approved for colitis first.

Read the full story at Web MD
Colitis

Irritable Bowel Syndrome: Symptoms, Treatment & Prevention


Amber Angelle, MyHealthNewsDaily Contributor   |   May 28, 2013 02:34pm ET

Common Stomach Bacteria
Irritable bowel syndrome (IBS) is a common disorder in Americans. According to the National Institute of Diabetes and Digestive and Kidney Diseases, one in every five men and women has IBS. Women are two times as likely to have the disorder. Half of all cases are diagnosed before age thirty-five.

Despite its high prevalence in the population, much is unknown about IBS. This is due in part because the area affected, the gastrointestinal (GI) tract, is so dynamic. The GI tract is comprised of the stomach, small intestine and colon (a.k.a. large intestine). It’s influenced by the immune and nervous systems, and contains hundreds of different types of bacteria that aid digestion.

 Read more at Live Science 
Colitis
Subscribe to: Posts (Atom)